Aurora Cannabis to File Dissident Circular Against Proposed CanniMed-Newstrike Combination Proposed Transaction Highly Dilutive and Wholly Inadequate for CanniMed Shareholders Aurora Appoints PI Financial as Advisor in Relation to...
Aurora Cannabis Rebuts CanniMed’s Call for Government Intervention to Block Takeover Bid Saskatchewan Government Rejects CanniMed CEO’s Plea Aurora Intends to Establish Medical Cannabis Centre of Excellence in Saskatchewan...
CanniMed Therapeutics (TSX: CMED) formally launched the proxy to acquire Newstrike Resources (TSXV: HIP) (OTC: NWKRF) and its Up Cannabis licensed producer unit. Shareholders will vote at a special...
Aurora Cannabis Responds to CanniMed’s Adoption of Poison Pill Tactic Reaffirms Commitment to Offer and Invitation to Tender Poison Pill Strips CanniMed Shareholders of Rights and Restricts Choices Not...
CanniMed Therapeutics Acts to Protect Shareholders from Aurora Cannabis’ Opportunistic Offer and Enable Fair Vote on Newstrike Acquisition with Shareholder Rights Plan SASKATOON, Saskatchewan — (Business Wire) — CanniMed...
Aurora Cannabis Launches Takeover Bid for CanniMed, Invites CanniMed Shareholders to Tender to the Bid Offer currently valued at $24.00 per CanniMed share 56.9% premium to CanniMed closing price...
Aurora Cannabis Announces Intention to Launch Takeover Bid for CanniMed Therapeutics Inc. Provides Comments on CanniMed’s Poison Pill Tactic Aurora’s proposed offer currently valued at $24.00 per CanniMed share...
CanniMed to Acquire Up Cannabis Inc. (Newstrike Resources Ltd. – TSX-V:HIP) to Create a Premier Global Cannabis Company November 17, 2017 SASKATOON, Saskatchewan & OAKVILLE, Ontario–(BUSINESS WIRE)–CanniMed Therapeutics Inc....
CanniMed Acknowledges Aurora Press Release and Announces Exclusivity Agreement and Intention to Acquire Newstrike Resources Ltd. Shareholders advised to take no action at this time. Details regarding acquisition transaction...
Aurora Cannabis Submits Proposal to CanniMed Therapeutics Board Aurora Cannabis Executes Lock-up Agreements with 38% of CanniMed Shareholders VANCOUVER, Nov. 14, 2017 /CNW/ – At the request of IIROC,...
The Canadian Cannabis Industry: Enter the Giants Guest Post by Michael Black, Director Consulting & Deals at PwC Canada The entrance of Constellation Brands in the cannabis industry has...
Despite a flood of supply this month, Canadian LP stock performance stands out so far in October as investors have retreated somewhat from the overall sector. The Cannabis Stock...
In September, Health Canada updated market information that showed how oils are growing rapidly. During the quarter ending 6/30, licensed producers (LPs) shipped 5.896mm grams of dried flower, representing...
Investment Bank Mackie Research has published an extensive industry report, initiating coverage on four Canadian LPs. The 74-page report, “The End of Prohibition – Investing in Canada’s Growing Cannabis...
Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North...
CanniMed Therapeutics Inc. Reports Financial Results for Q3 2017 SASKATOON, Saskatchewan–(BUSINESS WIRE)–CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the three and nine...
In contrast to a period when promotion and fluff have grabbed the attention of novice stock investors interested in the legal cannabis theme since early 2013, we are now seeing companies...
Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (OTC: HMLSF) has been hit hard over the past two weeks, declining 8.4% since July 26th despite what has been a stable market...
After a big 2nd half of 2016 and some strength in early 2017, Canadian LPs were under heavy pressure from April through June following a glut of supply (new...
Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015. While these products...
Earlier this month, Tilray made a big change in how it will be marketing its medical cannabis products. Historically, it was selling its dried cannabis products under common strain names,...
As the U.S. cannabis industry has evolved over the past few years, so has the market for publicly-traded cannabis stocks. In 2014, very few publicly-traded companies were reporting substantial...
Readers of New Cannabis Ventures likely recall how we alerted to the huge opportunities in Canada last June, and the Canadian market continues to evolve as a leader in the...
While Health Canada, which provided an update on April 24th, continues to get the official data out to the public very slowly, the patient enrollment growth in the ACMPR...
With Canada set to make history this week by tabling legislation to make the nation the first G-7 country to legalize cannabis for adult use, many investors are focusing...
